ZA923492B - Urapidil slow-release preparation - Google Patents

Urapidil slow-release preparation

Info

Publication number
ZA923492B
ZA923492B ZA923492A ZA923492A ZA923492B ZA 923492 B ZA923492 B ZA 923492B ZA 923492 A ZA923492 A ZA 923492A ZA 923492 A ZA923492 A ZA 923492A ZA 923492 B ZA923492 B ZA 923492B
Authority
ZA
South Africa
Prior art keywords
urapidil
slow
adjuvants
formulations
release preparation
Prior art date
Application number
ZA923492A
Inventor
Gerald Benedikt
Benedikt Gerald
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Priority to ZA923492A priority Critical patent/ZA923492B/en
Publication of ZA923492B publication Critical patent/ZA923492B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Described is a retarded-action formulation for urapidil, based on the principle of osmotic action, in which the active substance, together with adjuvants, is enclosed in a semi-permeable envelope with an outlet hole. The formulation is characterized in that it contains a readily soluble salt of urapidil as the active substance, plus sugars and/or sugar alcohols with a solubility of less than 30 % by wt. in water at 37 DEG C as adjuvants. Formulations of readily soluble urapidil salts can be prepared for once-daily or twice-daily administration, these formulations being characterized above all by a high bioavailability which is unaffected by the intake of food.
ZA923492A 1990-11-27 1992-05-14 Urapidil slow-release preparation ZA923492B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA923492A ZA923492B (en) 1990-11-27 1992-05-14 Urapidil slow-release preparation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH376390 1990-11-27
ZA923492A ZA923492B (en) 1990-11-27 1992-05-14 Urapidil slow-release preparation
CN92103927A CN1079147A (en) 1990-11-27 1992-05-23 Urapidil slow-release preparation

Publications (1)

Publication Number Publication Date
ZA923492B true ZA923492B (en) 1992-12-30

Family

ID=25693784

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923492A ZA923492B (en) 1990-11-27 1992-05-14 Urapidil slow-release preparation

Country Status (10)

Country Link
EP (1) EP0559702B1 (en)
CN (1) CN1079147A (en)
AT (1) ATE116133T1 (en)
AU (1) AU8941491A (en)
DE (2) DE59104100D1 (en)
DK (1) DK0559702T3 (en)
ES (1) ES2069317T3 (en)
GR (1) GR3015176T3 (en)
WO (1) WO1992009273A1 (en)
ZA (1) ZA923492B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101646420B (en) 2007-02-01 2012-11-07 武田药品工业株式会社 Solid preparation comprising alogliptin and pioglitazone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form

Also Published As

Publication number Publication date
CN1079147A (en) 1993-12-08
GR3015176T3 (en) 1995-05-31
ES2069317T3 (en) 1995-05-01
ATE116133T1 (en) 1995-01-15
DE4193036D2 (en) 1996-06-27
WO1992009273A1 (en) 1992-06-11
AU8941491A (en) 1992-06-25
EP0559702A1 (en) 1993-09-15
EP0559702B1 (en) 1994-12-28
DE59104100D1 (en) 1995-02-09
DK0559702T3 (en) 1995-05-15

Similar Documents

Publication Publication Date Title
ES2039264T3 (en) AQUEOUS OR PULVERULENT PREPARATION, WATER DISPERSIBLE OF A PHARMACEUTICALLY ACTIVE PRODUCT DIFFICULTLY SOLUBLE IN WATER AND PROCEDURE FOR ITS OBTAINING.
GB1405088A (en) Slow release formulation
CA1139768A (en) Mixed salts of essential or semi-essential amino acids and nitrogen-free analogues thereof and uses in treatment of renal and hepatic disorders
CA2125408A1 (en) Drug formulations for parenteral use
PT742714E (en) LIQUID PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THYROID HORMONES
SE8402551D0 (en) CINNAMOYLMORANOLIN DERIVATIVES
SE9203744L (en) PROCEDURES FOR PREPARING A PHARMACEUTICAL COMPOSITION SELECTIVELY LOWING THE LIPID LEVEL OF BLOOD
JPS51148013A (en) Stable insulin preparation for nosal administration
ES2041616T1 (en) PROCEDURE TO PRODUCE BIOACTIVE PRODUCTS DERIVED FROM THE PEAT.
EP0787497A3 (en) Pharmaceutical preparation containing human growth hormone
AU564166B2 (en) Protracted release microbiocidal articles
ATE220321T1 (en) ORAL DOSAGE FORMS CONTAINING SOLID FLUPIRTINE WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
EP0189377A3 (en) An agricultural composition with reduced toxicity to fishes and shellfishes
ZA894828B (en) Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base,with elimination,in solution,of the bitter taste,burning of the throat and intestinal toxicity
IE791995L (en) Formulation
ZA923492B (en) Urapidil slow-release preparation
JPS57146722A (en) Pharmaceutical preparation having improved absorption
Selye Induced hypersensitivity to cold
JPS57156412A (en) Preparation containing dextromethorphan hydrobromide
JPS55108814A (en) Preparation of stable, easily soluble, amorphous magnesium citrate powder for medical use
HU896426D0 (en) Process for the preparation of aquous solutions of doxorubicin
PT69808A (en) Process for preparing new n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ols and salts thereof
IE38235B1 (en) Preparations for combatting swine dysentery
EP1046345A3 (en) Preparation for administration to animals and feeding method thereof
JPS5780317A (en) Preparation of pharmaceutical composition for injection